CAIHF
Price
$0.28
Change
+$0.27 (+2700.00%)
Updated
May 28 closing price
Capitalization
204.55M
HKMPF
Price
$23.96
Change
-$2.42 (-9.17%)
Updated
Aug 11 closing price
Capitalization
5.38B
Interact to see
Advertisement

CAIHF vs HKMPF

Header iconCAIHF vs HKMPF Comparison
Open Charts CAIHF vs HKMPFBanner chart's image
Chia Tai Enterprises International
Price$0.28
Change+$0.27 (+2700.00%)
Volume$510
Capitalization204.55M
Hikma Pharmaceuticals
Price$23.96
Change-$2.42 (-9.17%)
Volume$300
Capitalization5.38B
CAIHF vs HKMPF Comparison Chart in %
Loading...
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAIHF vs. HKMPF commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAIHF is a Hold and HKMPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (CAIHF: $0.28 vs. HKMPF: $23.60)
Brand notoriety: CAIHF and HKMPF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CAIHF: 100% vs. HKMPF: 193%
Market capitalization -- CAIHF: $204.55M vs. HKMPF: $5.38B
CAIHF [@Pharmaceuticals: Generic] is valued at $204.55M. HKMPF’s [@Pharmaceuticals: Generic] market capitalization is $5.38B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAIHF’s FA Score shows that 1 FA rating(s) are green whileHKMPF’s FA Score has 1 green FA rating(s).

  • CAIHF’s FA Score: 1 green, 4 red.
  • HKMPF’s FA Score: 1 green, 4 red.
According to our system of comparison, CAIHF is a better buy in the long-term than HKMPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HKMPF’s TA Score shows that 3 TA indicator(s) are bullish.

  • HKMPF’s TA Score: 3 bullish, 4 bearish.

Price Growth

CAIHF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while HKMPF (@Pharmaceuticals: Generic) price change was -9.16% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPF($5.38B) has a higher market cap than CAIHF($205M). HKMPF has higher P/E ratio than CAIHF: HKMPF (14.35) vs CAIHF (2.72). CAIHF YTD gains are higher at: 2700.000 vs. HKMPF (1.199). HKMPF has higher annual earnings (EBITDA): 734M vs. CAIHF (6.29M). HKMPF has more cash in the bank: 127M vs. CAIHF (13.1M). CAIHF has less debt than HKMPF: CAIHF (78.2M) vs HKMPF (1.31B). HKMPF has higher revenues than CAIHF: HKMPF (3.22B) vs CAIHF (199M).
CAIHFHKMPFCAIHF / HKMPF
Capitalization205M5.38B4%
EBITDA6.29M734M1%
Gain YTD2700.0001.199225,148%
P/E Ratio2.7214.3519%
Revenue199M3.22B6%
Total Cash13.1M127M10%
Total Debt78.2M1.31B6%
FUNDAMENTALS RATINGS
CAIHF vs HKMPF: Fundamental Ratings
CAIHF
HKMPF
OUTLOOK RATING
1..100
3389
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
9
Undervalued
PROFIT vs RISK RATING
1..100
62100
SMR RATING
1..100
8977
PRICE GROWTH RATING
1..100
3480
P/E GROWTH RATING
1..100
395
SEASONALITY SCORE
1..100
650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPF's Valuation (9) in the null industry is somewhat better than the same rating for CAIHF (48). This means that HKMPF’s stock grew somewhat faster than CAIHF’s over the last 12 months.

CAIHF's Profit vs Risk Rating (62) in the null industry is somewhat better than the same rating for HKMPF (100). This means that CAIHF’s stock grew somewhat faster than HKMPF’s over the last 12 months.

HKMPF's SMR Rating (77) in the null industry is in the same range as CAIHF (89). This means that HKMPF’s stock grew similarly to CAIHF’s over the last 12 months.

CAIHF's Price Growth Rating (34) in the null industry is somewhat better than the same rating for HKMPF (80). This means that CAIHF’s stock grew somewhat faster than HKMPF’s over the last 12 months.

CAIHF's P/E Growth Rating (3) in the null industry is significantly better than the same rating for HKMPF (95). This means that CAIHF’s stock grew significantly faster than HKMPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAIHFHKMPF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
32%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
44%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
31%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
30%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
5%
Bearish Trend 2 days ago
29%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
4%
Bearish Trend 2 days ago
39%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
39%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHIAX20.200.09
+0.45%
Diamond Hill International Inv
DRTCX20.95N/A
N/A
BNY Mellon Sust US Equity I
FQITX13.70N/A
N/A
Fidelity SAI International Qly Idx
ABRUX14.85N/A
N/A
DSS AmericaFirstMonthlyRisk-OnRisk-Off U
FIKMX12.12N/A
N/A
Fidelity Advisor Real Estate Income Z

CAIHF and

Correlation & Price change

A.I.dvisor tells us that CAIHF and INDV have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CAIHF and INDV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAIHF
1D Price
Change %
CAIHF100%
N/A
INDV - CAIHF
27%
Poorly correlated
+1.25%
HKMPF - CAIHF
24%
Poorly correlated
N/A
LNTH - CAIHF
22%
Poorly correlated
-0.53%
CANN - CAIHF
12%
Poorly correlated
-9.82%
BSPK - CAIHF
4%
Poorly correlated
N/A
More

HKMPF and

Correlation & Price change

A.I.dvisor tells us that HKMPF and AMPH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPF and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPF
1D Price
Change %
HKMPF100%
N/A
AMPH - HKMPF
24%
Poorly correlated
-1.26%
CAIHF - HKMPF
24%
Poorly correlated
N/A
HLTRF - HKMPF
11%
Poorly correlated
+0.27%
GRUSF - HKMPF
9%
Poorly correlated
-3.00%
ESALF - HKMPF
7%
Poorly correlated
+0.32%
More